This is the new MLex platform. Existing customers should continue to use the existing MLex platform until migrated.
For any queries, please contact Customer Services or your Account Manager. Dismiss

​Essilor-Luxottica merger review moves to second phase in Singapore

( December 12, 2017, 04:03 GMT | Official Statement) -- MLex Summary: The Competition Commission of Singapore has initiated an in-depth, or Phase 2, review of the proposed merger of Essilor International and Luxottica Group over concerns the merged entity would have substantial market power in the complementary products of ophthalmic lenses, prescription frames and sunglasses. The regulator said the companies have argued their activities have minimal overlap in Singapore. A Phase 2 review can take up to 120 working days to complete.The regulator's full statement is attached. ...

Prepare for tomorrow’s regulatory change, today

MLex identifies risk to business wherever it emerges, with specialist reporters across the globe providing exclusive news and deep-dive analysis on the proposals, probes, enforcement actions and rulings that matter to your organization and clients, now and in the longer term.


Know what others in the room don’t, with features including:

  • Daily newsletters for Antitrust, M&A, Trade, Data Privacy & Security, Technology, AI and more
  • Custom alerts on specific filters including geographies, industries, topics and companies to suit your practice needs
  • Predictive analysis from expert journalists across North America, the UK and Europe, Latin America and Asia-Pacific
  • Curated case files bringing together news, analysis and source documents in a single timeline

Experience MLex today with a 14-day free trial.

Start Free Trial

Already a subscriber? Click here to login

Documents

Related Sections